Forced expression of wildtype PTEN reduces the metastatic potential of melanoma cells in a dose-dependent manner, whereas expression of a PTEN phosphatase mutant promotes metastatic melanoma behavior in a dominant-negative manner. The gene discussed is PTEN; the disease is melanoma.